Expected years of life lost due to adult cancer mortality in Yazd (2004-2010)

Asian Pacific Journal of Cancer Prevention

Volumn 17, Issue , 2016, Pages 101-105

  Mirzaei, Mohsen ^a   Mirzadeh, Mahboobahsadat ^b   Mirzaei, Mojtaba ^c  

^a SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cancer; Iran; Mortality; Years of life lost

Indexed keywords

ADULT; AGED; CAUSE OF DEATH; FEMALE; FOLLOW UP; HEALTH DISPARITY; HEALTH STATUS; HUMAN; IRAN; LIFE EXPECTANCY; LONGEVITY; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TRENDS;

ADULT; AGED; CAUSE OF DEATH; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HEALTH STATUS DISPARITIES; HUMANS; IRAN; LIFE EXPECTANCY; LONGEVITY; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; PROGNOSIS; SURVIVAL RATE;

EID: 85011990074     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2016.17.S3.101     Document Type: Article

References (40)

1. Anand P, Kunnumakara AB, Sundaram C, et al (2008). Cancer is a preventable disease that requires major lifestyle changes. Pharm Res, 25, 2097-116
2. Aragon TJ, Lichtensztajn DY, Katcher BS, et al (2008). Calculating expected years of life lost for assessing local ethnic disparities in causes of premature death. BMC Public Health, 8, 116
3. Baeradeh NA, Lotfi MH, Fallahzadeh H, et al (2015). Survival rate of patients with stomach cancer and its effective factors in Yazd province. Journal of Community health Research, 3, 278-87
4. Brustugun OT, Moller B, Helland A (2014). Years of life lost as a measure of cancer burden on a national level. Br J Cancer, 111, 1014-20
5. Burnet NG, Jefferies SJ, Benson RJ, et al (2005). Years of life lost (YLL) from cancer is an important measure of population burden-and should be considered when allocating research funds. Br J Cancer, 92, 241-5
6. Carter AJ, Nguyen CN (2012). A comparison of cancer burden and research spending reveals discrepancies in the distribution of research funding. BMC public health, 12, 526
7. Chu DM, Wahlqvist ML, Lee MS, et al (2011). Central obesity predicts non-Hodgkin's lymphoma mortality and overall obesity predicts leukemia mortality in adult Taiwanese. J Am Coll Nutr, 30, 310-9
8. Etemadi A, Sadjadi A, Semnani S, et al (2008). Cancer registry in Iran: a brief overview. Arch Iran Med, 11, 577-80
9. Fallahzadeh H, Momayyezi M, Akhundzardeini R, et al (2014). Five year survival of women with breast cancer in Yazd. Asian Pac J Cancer Prev, 15, 6597-601
10. Fateh M, Emamian MH (2013). Cancer Incidence and Trend Analysis in Shahroud, Iran, 2000-2010. Iran J Cancer Prev, 6, 85-94
11. Fazeli Z, Pourhoseingholi MA, Vahedi M, et al (2013). Leukemia cancer mortality trend in Iran, From 1995 to 2004. Iran J Cancer Prev, 6, 170-3
12. Fitzmaurice C, Dicker D, Pain A, et al (2015). The Global burden of cancer 2013. JAMA Oncol, 1, 505-27
13. Gardner JW, Sanborn JS (1990). Years of potential life lost (YPLL)-what does it measure?. Epidemiology, 1, 322-9
14. Hadad K, Mokhtari J (2015). Indoor radon variations in central Iran and its geostatistical map. Atmos. Environ, 102, 220-7
15. Harirchi I, Ghaemmaghami F, Karbakhsh M, et al (2005). Patient delay in women presenting with advanced breast cancer: an Iranian study. Public Health, 119, 885-91
16. Hassan LM, Mahmoud N, Miller AB, et al (2015). Evaluation of effect of self-examination and physical examination on breast cancer. Breast J, 24, 491-6
17. Imamura Y, Mizuno S (2005). Comparison of leukemia mortality in five countries: France, Italy, Japan, UK and USA from the WHO mortality database (1960-2000). Jpn J Clin Oncol, 35, 420-3
18. Keyghobadi N, Rafiemanesh H, Mohammadian-Hafshejani A, et al (2015). Epidemiology and trend of cancers in the province of Kerman: southeast of Iran. Asian Pac J Cancer Prev, 16, 1409-13
19. Khajedaluee M, Dadgarmoghaddam M, Saeedi R, et al (2014). Mortality, morbidity, survival, and burden of top 9 cancers in a developing country. Razavi Int J Med, 2, 20073
20. Khan A (2000). A study of indoor radon levels in Indian dwellings, influencing factors and lung cancer risks. Radiat. Meas, 32, 87-92
21. Khorasani S, Rezaei S, Rashidian H, et al (2015). Years of potential life lost and productivity costs due to premature cancer-related mortality in Iran. Asian Pac J Cancer Prev, 16, 1845-50
22. Kushi LH, Doyle C, McCullough M, et al (2012). American cancer society guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity. CA Cancer J Clin, 62, 30-67
23. Lee WC (1997). Quantifying the future impact of disease on society: life table-based measures of potential life lost. Am. J Public Health, 87, 1456-60
24. Liu PH, Wang JD, Keating NL (2013). Expected years of life lost for six potentially preventable cancers in the United States. Prev Med, 56, 309-13
25. Lotfi M, Shobairi SCS (2008). Breast cancer risk factors in an urban area of Yazd City-Iran, 2006. Acta Med Iranica, 46, 253-7
26. Lozano R, Naghavi M, Foreman K, et al (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380, 2095-128
27. Malekzadeh R, Derakhshan MH, Malekzadeh Z (2009). Gastric cancer in Iran: epidemiology and risk factors. Arch Iran Med, 12, 576-83
28. Miller AB, Harirchi I, Lotfi MH, et al (2015). Yazd breast cancer project profile; a community based trial for the evaluation of self-examination and physical examination of the breast cancer disease. Iran J Basic Med Sci, 40, 531-6
29. Mirzadeh M, Mirzaei M, Mirzaei M, et al (2015). Years of Life Lost and Childhood and Adolescent Cancer Mortality in Yazd Province, Iran (2004-2009). Iran J Ped Hematol Oncol, 5, 125-30
30. Mojibyan M, Karimi M, Bidaki R, et al (2013). Exposure to second-hand smoke during pregnancy and preterm delivery. Int J High Risk Behav, 1, 149-53
31. Naghavi M, Abolhassani F, Pourmalek F, et al (2009). The burden of disease and injury in Iran 2003. Popul Health Metr, 7, 9
32. Namayandeh S, Sadr S, Ansari Z, et al (2011). A cross-sectional study of the prevalence of coronary artery disease traditional risk factors in Yazd urban population, Yazd healthy heart project. Int J Cardiovasc Res, 5, 7-13
33. Pirsaheb M, Najafi F, Khosravi T, et al (2013). A systematic review of radon investigations related to public exposure in Iran. Iran. Red. Crescent, 15, 10204
34. Rouse C, Gittleman H, Ostrom QT, et al (2015). Years of potential life lost for brain and CNS tumors relative to other cancers in adults in the United States, 2010. Neuro Oncol, 4, 608-619
35. Thun MJ, DeLancey JO, Center MM, et al (2010). The global burden of cancer: priorities for prevention. J Carcinog, 31, 100-10
36. Vakili M, Pirdehghan A, Adimi M, et al (2014). Epidemiology and trend of cancer in Yazd, a central province of Iran, 2005-2009. J Res Health Sci, 14, 210-3
37. Varadarajan R, Cummings MK, Hyland AJ, et al (2010). Can decreasing smoking prevalence reduce leukemia mortality?. Ann Hematol, 89, 873-6
38. Yalla M, Abedini M, Hassanzadeh R (2013). Life expectancy in brain tumor patients and healthy subjects. Intl Res J Appl Basic Sci, 5, 251-4
39. Zahedi A, Rafiemanesh H, Enayatrad M, et al (2015). Incidence, trends and epidemiology of cancers in North West of Iran. Asian Pac J Cancer Prev, 16, 7189-93
40. Zeinalzadeh AH, Kousha A, Abdullahi L, et al (2012). Pattern of age distribution of different cancers in East Azerbaijan province, Iran. J Kerman Univ Med Sci, 19, 308-86